OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Safety and efficacy of lirentelimab in patients with refractory indolent systemic mastocytosis: a first-in-human clinical trial
Frank Siebenhaar, Sabine Altrichter, Hanna Bonnekoh, et al.
British Journal of Dermatology (2023) Vol. 189, Iss. 5, pp. 511-519
Closed Access | Times Cited: 16
Frank Siebenhaar, Sabine Altrichter, Hanna Bonnekoh, et al.
British Journal of Dermatology (2023) Vol. 189, Iss. 5, pp. 511-519
Closed Access | Times Cited: 16
Showing 16 citing articles:
Immunomodulatory Significance of Mast Cell Exosomes (MC-EXOs) in Immune Response Coordination
Daniel Elieh Ali Komi, Farzaneh Shafaghat, Shamila D. Alipoor, et al.
Clinical Reviews in Allergy & Immunology (2025) Vol. 68, Iss. 1
Open Access
Daniel Elieh Ali Komi, Farzaneh Shafaghat, Shamila D. Alipoor, et al.
Clinical Reviews in Allergy & Immunology (2025) Vol. 68, Iss. 1
Open Access
Global productivity, international collaborations, and research trends in chronic spontaneous urticaria: A bibliometric overview
Hugo W.F. Mak, Freya K L Chung, Philip H. Li, et al.
Journal of Allergy and Clinical Immunology Global (2025), pp. 100455-100455
Open Access
Hugo W.F. Mak, Freya K L Chung, Philip H. Li, et al.
Journal of Allergy and Clinical Immunology Global (2025), pp. 100455-100455
Open Access
Siglecs as potential targets of therapy in human mast cell- and/or eosinophil-associated diseases
Jeremy A. O’Sullivan, Bradford A. Youngblood, Robert P. Schleimer, et al.
Seminars in Immunology (2023) Vol. 69, pp. 101799-101799
Open Access | Times Cited: 10
Jeremy A. O’Sullivan, Bradford A. Youngblood, Robert P. Schleimer, et al.
Seminars in Immunology (2023) Vol. 69, pp. 101799-101799
Open Access | Times Cited: 10
Diffuse Cutaneous Mastocytosis: A Current Understanding of a Rare Disease
Agnieszka Rydz, Magdalena Lange, Hanna Ługowska‐Umer, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1401-1401
Open Access | Times Cited: 3
Agnieszka Rydz, Magdalena Lange, Hanna Ługowska‐Umer, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1401-1401
Open Access | Times Cited: 3
Detecting Changes in Mast Cell Numbers Versus Activation in Human Disease: A Roadblock for Current Biomarkers?
Cem Akin, Frank Siebenhaar, Joshua B. Wechsler, et al.
The Journal of Allergy and Clinical Immunology In Practice (2024) Vol. 12, Iss. 7, pp. 1727-1737
Open Access | Times Cited: 3
Cem Akin, Frank Siebenhaar, Joshua B. Wechsler, et al.
The Journal of Allergy and Clinical Immunology In Practice (2024) Vol. 12, Iss. 7, pp. 1727-1737
Open Access | Times Cited: 3
Mast Cell–Targeting Therapies in Mast Cell Activation Syndromes
Vito Sabato, Michiel Beyens, Alessandro Toscano, et al.
Current Allergy and Asthma Reports (2024) Vol. 24, Iss. 2, pp. 63-71
Closed Access | Times Cited: 2
Vito Sabato, Michiel Beyens, Alessandro Toscano, et al.
Current Allergy and Asthma Reports (2024) Vol. 24, Iss. 2, pp. 63-71
Closed Access | Times Cited: 2
Roles for Siglec-glycan interactions in regulating immune cells
S. C. Lin, Edward N. Schmidt, Kei Takahashi, et al.
Seminars in Immunology (2024) Vol. 77, pp. 101925-101925
Open Access | Times Cited: 1
S. C. Lin, Edward N. Schmidt, Kei Takahashi, et al.
Seminars in Immunology (2024) Vol. 77, pp. 101925-101925
Open Access | Times Cited: 1
The diagnostic workup for systemic mastocytosis differs from consensus recommendations: Results of a worldwide survey
Polina Pyatilova, Jonathan A. Bernstein, Felix Aulenbacher, et al.
World Allergy Organization Journal (2023) Vol. 16, Iss. 11, pp. 100838-100838
Open Access | Times Cited: 3
Polina Pyatilova, Jonathan A. Bernstein, Felix Aulenbacher, et al.
World Allergy Organization Journal (2023) Vol. 16, Iss. 11, pp. 100838-100838
Open Access | Times Cited: 3
Approach to the patient with eosinophilia in the era of tyrosine kinase inhibitors and biologicals
Johannes Lübke, Georgia Metzgeroth, Andreas Reiter, et al.
Current Hematologic Malignancy Reports (2024) Vol. 19, Iss. 5, pp. 208-222
Open Access
Johannes Lübke, Georgia Metzgeroth, Andreas Reiter, et al.
Current Hematologic Malignancy Reports (2024) Vol. 19, Iss. 5, pp. 208-222
Open Access
Systemic Mastocytosis: State of the Art
Isabel Farmer, Deepti Radia
Current Hematologic Malignancy Reports (2024) Vol. 19, Iss. 5, pp. 197-207
Closed Access
Isabel Farmer, Deepti Radia
Current Hematologic Malignancy Reports (2024) Vol. 19, Iss. 5, pp. 197-207
Closed Access
Bruno Brando
Cytometry Part B Clinical Cytometry (2024) Vol. 106, Iss. 5, pp. 327-330
Closed Access
Optimizing Siglec-8-Directed Immunotherapy for Eosinophilic and Mast Cell Disorders
Sheryl Y. T. Lim, Jenny Huo, George S. Laszlo, et al.
Cancers (2024) Vol. 16, Iss. 20, pp. 3476-3476
Open Access
Sheryl Y. T. Lim, Jenny Huo, George S. Laszlo, et al.
Cancers (2024) Vol. 16, Iss. 20, pp. 3476-3476
Open Access
Siglecs-mediated immune regulation in neurological disorders
Hung‐Ya Tu, Limei Yuan, Bo Ni, et al.
Pharmacological Research (2024) Vol. 210, pp. 107531-107531
Open Access
Hung‐Ya Tu, Limei Yuan, Bo Ni, et al.
Pharmacological Research (2024) Vol. 210, pp. 107531-107531
Open Access
Vectorized Human Antibody-Mediated Anti-Eosinophil Gene Therapy
Maria Gioulvanidou, Selenay S. Sarklioglu, Xinlei Chen, et al.
Human Gene Therapy (2024)
Closed Access
Maria Gioulvanidou, Selenay S. Sarklioglu, Xinlei Chen, et al.
Human Gene Therapy (2024)
Closed Access
Is lirentelimab the ‘magic bullet’ to fight pathological mast-cell activation in systemic mastocytosis?
Stéphane Barète, Michel Arock
British Journal of Dermatology (2023) Vol. 189, Iss. 5, pp. 503-504
Closed Access
Stéphane Barète, Michel Arock
British Journal of Dermatology (2023) Vol. 189, Iss. 5, pp. 503-504
Closed Access
Quoi de neuf en thérapeutique dermatologique ?
M. Samimi
Annales de Dermatologie et de Vénéréologie - FMC (2023) Vol. 3, Iss. 8, pp. 8S50-8S65
Closed Access
M. Samimi
Annales de Dermatologie et de Vénéréologie - FMC (2023) Vol. 3, Iss. 8, pp. 8S50-8S65
Closed Access
